UNSPSC 85251520: Diagnosis of malignant neoplasm on the tonsillar fossa

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Tonsillar fossa. Malignant neoplasm on the Tonsillar fossa is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C09. 0

UNSPSC 85251520 Diagnosis of malignant neoplasm on the tonsillar fossa is a Commodity code with minimal alignment to recent state and local procurement activity. The code's nominal scope—diagnostic services for a specific cancer type—does not match the health system solicitations in the recent-opportunities record. The three posted opportunities span diagnostic imaging infrastructure (Picture Archiving and Communication System software and implementation), special education contracted services (speech language therapy, occupational therapy, and related professionals), and temporary health professional staffing across ancillary clinical categories (audiology, diagnostic imaging, surgical services, therapy services). While some of these services touch diagnostic and clinical work, none target tonsillar fossa malignancy diagnosis specifically, and the code shows no concrete recent solicitation activity directly within its stated scope.

The issuing bodies across the recent opportunities include San Mateo County (a county health system), Birdville Independent School District (a school district in Texas), and Santa Clara County (a county health system). Geographic activity appears concentrated in California (San Mateo, Santa Clara) and Texas (Tarrant County), but the mismatch between the code's intended scope and the actual work being solicited means this code does not represent a current market signal for state and local procurement. Prospective vendors should verify whether opportunities tagged to this code in their region align with their service offerings before pursuing; the code's recent posting volume and issuer mix do not indicate active, focused demand for tonsillar fossa malignancy diagnosis services in the state and local procurement market.